Stay updated on Fremanezumab in Preventing Chronic Migraine Clinical Trial

Sign up to get notified when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fremanezumab in Preventing Chronic Migraine Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Results Posted including Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and updated Study Status (Revision: v3.3.3, 2025-12-19). Previous entry 'Results Submitted' and 'HHS Vulnerability Disclosure' removed (Revision: v3.3.2, 2025-10-28).
    Difference
    0.5%
    Check dated 2025-12-23T12:27:13.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The Record History now shows revision v3.3.2 with a Returned date of 2025-11-21 and a QC status of Not Concluded. New sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and other document sections were added, and the Study Status was updated.
    Difference
    0.5%
    Check dated 2025-11-24T18:05:56.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The history shows a new 'Results Submitted' status and removes the 'No Results Posted' notice, indicating that trial results have been submitted.
    Difference
    0.3%
    Check dated 2025-11-17T17:54:57.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A new 'Study Status' entry was added to the record history on 2025-10-28, corresponding to version 83 listed on 2025-10-27.
    Difference
    0.2%
    Check dated 2025-11-03T12:38:45.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The study title changed from “Patients 6 to 17 Years of Age” to “Participants 6 to 17 Years of Age,” the date updated from 2025-01-29 to 2025-10-06, and new metadata sections (Study Identification, Status, Design, Arms and Interventions, Outcome Measures, Eligibility) were added.
    Difference
    2%
    Check dated 2025-10-13T03:09:24.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    8%
    Check dated 2025-10-05T17:34:37.000Z thumbnail image

Stay in the know with updates to Fremanezumab in Preventing Chronic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.